IFP Advisors’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2
| Closed | -$1 | – | 4569 |
|
2024
Q4 | $1 | Buy |
+2
| New | +$1 | ﹤0.01% | 4588 |
|
2024
Q3 | – | Sell |
-13
| Closed | -$102 | – | 3398 |
|
2024
Q2 | $102 | Hold |
13
| – | – | ﹤0.01% | 3168 |
|
2024
Q1 | $174 | Hold |
13
| – | – | ﹤0.01% | 3037 |
|
2023
Q4 | $139 | Hold |
13
| – | – | ﹤0.01% | 2957 |
|
2023
Q3 | $83 | Hold |
13
| – | – | ﹤0.01% | 3227 |
|
2023
Q2 | $231 | Hold |
13
| – | – | ﹤0.01% | 3304 |
|
2023
Q1 | $383 | Hold |
13
| – | – | ﹤0.01% | 3216 |
|
2022
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 4187 |
|
2022
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 4382 |
|
2022
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 4154 |
|
2022
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 4154 |
|
2021
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 2768 |
|
2021
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 2818 |
|
2021
Q2 | $0 | Sell |
13
-254
| -95% | – | ﹤0.01% | 3877 |
|
2021
Q1 | $14K | Buy |
267
+67
| +34% | +$3.51K | ﹤0.01% | 1990 |
|
2020
Q4 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 1928 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 3507 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3351 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 3297 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 3324 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 3422 |
|
2019
Q1 | – | Sell |
-35,500
| Closed | -$1.08M | – | 3000 |
|
2018
Q4 | $1.08M | Buy |
35,500
+24,477
| +222% | +$747K | 0.07% | 333 |
|
2018
Q3 | $507K | Hold |
11,023
| – | – | 0.02% | 651 |
|
2018
Q2 | $239K | Buy |
11,023
+6,000
| +119% | +$130K | 0.01% | 972 |
|
2018
Q1 | $291K | Hold |
5,023
| – | – | 0.01% | 835 |
|
2017
Q4 | $291K | Sell |
5,023
-8,977
| -64% | -$520K | 0.01% | 833 |
|
2017
Q3 | $924K | Hold |
14,000
| – | – | 0.04% | 463 |
|
2017
Q2 | $1.18M | Buy |
+14,000
| New | +$1.18M | 0.05% | 384 |
|